MedTrace Logo

A Pap Test Intervention to Enhance Decision Making Among Pacific Islander Women

NCT03064581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1014

Last updated 2017-02-27

No results posted yet for this study

Summary

This community-based randomized trial tested the effects of a social support intervention to increase Chamorro, Samoan, and Tongan women's Pap test behavior and social support among their male spouses or significant others in Southern California.

Conditions

Interventions

BEHAVIORAL

Intervention

The educational session consisted of a one-hour small group discussion (5-10 people). Gender-specific community health educators facilitated sessions for Pacific Islander women and for their spouses/significant others that included an educational video and other materials (brochure, calendar, and resource list). The video emphasized the importance of Pap testing for Pacific Islander women, and showed men supporting their women to get tested. Women's sessions provided basic information on cervical cancer and pap testing, and ended with verbal commitments and target screening dates by women to get screened. The men's education sessions contained similar information, with supplemental information on how to provide support for their wives to get tested and exercises on showing their support.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • California State University, Fullerton

    lead OTHER

Principal Investigators

  • Sora Park Tanjasiri, DrPH · California State University, Fullerton

  • Lola Sablan-Santos · Guam Communications Network

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064581 on ClinicalTrials.gov